News for Willow Biosciences Inc. (CANSF)

PR NewswireCALGARY, AB, May 12, 2025 CALGARY, AB, May 12, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF

Willow Biosciences (OTCQB: CANSF, TSX: WLLW) reports its unaudited Q1 2025 financials. The Company is transitioning to "Atlas Energy Corp." with new lea

Willow Biosciences (CANSF) has completed the sale of its operating subsidiary, Epimeron USA, for US$2.76 million in cash. Following the sale, significan

PR NewswireCALGARY, AB, April 30, 2025 CALGARY, AB, April 30, 2025 /PRNewswire/ - Willow Biosciences Inc. (the "Company") (TSX: WLLW) (OTCQB: CANSF) announ

PR NewswireSUNNYVALE, Calif., April 25, 2025 SUNNYVALE, Calif., April 25, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLL

Willow Biosciences (TSX: WLLW, OTCQB: CANSF) announced key approvals from its 2025 annual general and special meeting. Strong shareholder support for bo

PR NewswireSUNNYVALE, Calif., Jan. 20, 2025 SUNNYVALE, Calif., Jan. 20, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW)

WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Willow Biosciences Inc., (OTC: CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and operational results Tuesday morning for the fourth quarter and fiscal year 2023.

Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record revenue in 2023 of $1.2 million representing 43% growth over 2022...

CALGARY, AB, Feb. 29, 2024 /PRNewswire/ - Willow Biosciences Inc.  , a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...

Funds will be used for development of natural food ingredients.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) has reported its financial and operating results for the third quarter ending September 30, 2023, showcasing record revenue and substantial progress in its business expansion.

Aurora Cannabis Announces Settlement of Patent Litigation Aurora Cannabis Inc. (NASDAQ: ACB)…

/PRNewswire/ - Willow Biosciences Inc., ("Willow") (TSX: WLLW) (OTCQB: CANSF) and SUANFARMA today jointly announced execution of a collaboration agreement for...

MIAMI, Aug. 08, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 60th Emerging...

MIAMI, June 13, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 59th Emerging...

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the marijuana industry, let